Home » Topics » Regulatory

Regulatory
RSS

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

IVAX's generic estazolam cleared for marketing by FDA

July 8, 1997

Royce Laboratories' generic meperidine approved by FDA

July 8, 1997

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.